First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs.
- DOI
- 10.2147/ceor.s598572
- Published
- 2026
- Container
- ClinicoEconomics and outcomes research : CEOR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/ceor.s598572,
title = {First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs.},
author = {Perrone V and Innao V and Mazzoni S and Cappuccilli M and Andretta M and Bartolini F and Chinellato A and Dell'Orco S and Ferrante F and Lombardi R and Pagliaro R and Ubertazzo L and Valpondi P and Degli Esposti L},
year = {2026},
journal = {ClinicoEconomics and outcomes research : CEOR},
doi = {10.2147/ceor.s598572},
url = {https://doi.org/10.2147/ceor.s598572}
}RIS
TY - JOUR TI - First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs. AU - Perrone V AU - Innao V AU - Mazzoni S AU - Cappuccilli M AU - Andretta M AU - Bartolini F AU - Chinellato A AU - Dell'Orco S AU - Ferrante F AU - Lombardi R AU - Pagliaro R AU - Ubertazzo L AU - Valpondi P AU - Degli Esposti L PY - 2026 JO - ClinicoEconomics and outcomes research : CEOR DO - 10.2147/ceor.s598572 UR - https://doi.org/10.2147/ceor.s598572 ER -
APA
V, P., V, I., S, M., M, C., M, A., F, B., A, C., S, D., F, F., R, L., R, P., L, U., P, V., & L, D. E. (2026). First-Line Treatment of Chronic Lymphocytic Leukemia in Italy: Real-World Evidence on Utilization, Outcomes, and Healthcare Costs.. ClinicoEconomics and outcomes research : CEOR. https://doi.org/10.2147/ceor.s598572
Source records
- pubmed · retrieved 2026-09-26T09:58:57.700Z